These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 8584618

  • 1. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.
    Fiorella D, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618
    [Abstract] [Full Text] [Related]

  • 2. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
    Fiorella D, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
    [Abstract] [Full Text] [Related]

  • 3. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D, Helsley S, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
    [Abstract] [Full Text] [Related]

  • 4. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH.
    Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
    [Abstract] [Full Text] [Related]

  • 5. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D, Palumbo PA, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [Abstract] [Full Text] [Related]

  • 6. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
    Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC.
    Pharmacol Biochem Behav; 2003 Jul; 75(4):845-52. PubMed ID: 12957227
    [Abstract] [Full Text] [Related]

  • 7. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
    Helsley S, Fiorella D, Rabin RA, Winter JC.
    Pharmacol Biochem Behav; 1998 Feb; 59(2):419-25. PubMed ID: 9476990
    [Abstract] [Full Text] [Related]

  • 8. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
    Arvanov VL, Liang X, Russo A, Wang RY.
    Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
    [Abstract] [Full Text] [Related]

  • 9. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. III: The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion.
    Fiorella D, Helsley S, Lorrain DS, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Oct; 121(3):364-72. PubMed ID: 8584619
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB, Rutledge MA, Carbonaro T, Forster MJ.
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
    Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M.
    Psychopharmacology (Berl); 1998 Apr; 136(4):409-14. PubMed ID: 9600588
    [Abstract] [Full Text] [Related]

  • 13. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ, Commissaris RL, Warner MR, Rech RH.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [Abstract] [Full Text] [Related]

  • 14. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ, Rech RH.
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [Abstract] [Full Text] [Related]

  • 15. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
    Halberstadt AL, Geyer MA.
    Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
    [Abstract] [Full Text] [Related]

  • 16. Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats.
    Heym J, Rasmussen K, Jacobs BL.
    Eur J Pharmacol; 1984 May 18; 101(1-2):57-68. PubMed ID: 6745319
    [Abstract] [Full Text] [Related]

  • 17. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ, Aghajanian GK.
    J Pharmacol Exp Ther; 1996 Sep 18; 278(3):1373-82. PubMed ID: 8819525
    [Abstract] [Full Text] [Related]

  • 18. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
    White FJ, Appel JB.
    Psychopharmacology (Berl); 1981 Sep 18; 73(2):110-5. PubMed ID: 6785800
    [Abstract] [Full Text] [Related]

  • 19. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA, Young R, Rosecrans JA.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):189-96. PubMed ID: 6617740
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.